Get a glimpse into our company and investor data—powered by the PitchBook Platform
Conv. DebtLATEST DEAL TYPE
$355KLATEST DEAL AMOUNT
Developer of a drug for treatment of osteoporosis in women. The company is focused on women's health and is involved in developing a new formulation of lasofoxifene which is used for treatment of osteoporosis and other diseases.